July 5, 2014- Interviewed by Steven E. Greer, MD
The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas” being developed by engineers at Boston University and medical doctors at Massachusetts General hospital. We interviewed Ed Damiano, PhD, the lead biomedical engineer, and Steven Russell, MD PhD, the lead endocrinologist.
In Part 3, we asked them how their small lab funded only by the NIH succeeded at developing the bionic pancreas when large companies, such as Roche, Medtronic, Abbott, and JNJ all failed.
October 19, 2014- Interviewed by Steven E. Greer, MD
Did you know that one out of three Americans think that they are “gluten intolerant”. Of those 100 Million people, only 13 Million really have a medical problem caused by gluten.
Alessio Fasano, MD, director of the Center for Celiac Research and Treatment at MassGeneral Hospital for Children, is the man who started all of the gluten hype back in 2003 with a paper in the Archives of Internal Medicine. Hoping to reduce some of the current “gluten hysteria,” he has written a book explaining what gluten is, who can and can’t eat it, and why. We interviewed him.
Book reviews, Diabetes, Gastroenterology/Hepatology, Harvard affiliates, Internal medicine, Internal medicine/microbiology immunology, NEJM, Nutrition, Pediatrics, Policy | apples49 | 
June 4, 2015 12:39 pm | 
Comments (0)
April 26, 2015- By Steven E. Greer, MD
I was eating at a French restaurant recently, and the waiter asked me if I had any allergies, such as “gluten”. This greatly upset me, because the waiter was forced to asked this. Read more »
April 10, 2015- By Steven E. Greer, MD
Ten years ago, Tiger Woods hit one of the most memorable shots in golf when he chipped in a birdie on the 16th hole at Augusta in the Read more »
March 7, 2015- By Steven E. Greer, MD
The coffee industry has been funding mounds of junk science that purport to show the health benefits of drinking coffee, when in fact, coffee is very unhealthy to heart, brain, and blood vessels because Read more »
January 24, 2014- Interviewed by Steven E. Greer, MD
Erik Dutson, MD, weight loss surgeon at UCLA, explains why his medical center does not implant the Lap-Band, and how the “sleeve” bypass is the main procedure of choice now for weight loss surgery.
July 2, 2014- Interviewed by Steven E. Greer, MD
The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas” being developed by engineers at Boston University and medical doctors at Massachusetts General hospital. We interviewed Ed Damiano, PhD, the lead biomedical engineer, and Steven Russell, MD PhD, the lead endocrinologist. In Part 1, they review the clinical data.
The research was funded by the NIH and not a medical device or drug company. The researchers selected the components based on merit. They chose the Dexcom G4 Platinum continuous glucose sensor and a Tandem Diabetes t:slim pump, and used software that ran on a standard Apple iPhone 4S.
In Part 2, the team discusses the details of the pivotal study, that could be concluded by 2016, allowing for an FDA approval by 2017. Industry partners yet to be determined would be involved. However, the final marketed product will not require any particular smartphone to be used by the patient.
Boston University, Diabetes, Endocrinology, FDA, Harvard affiliates, Internal medicine, Medical Devices, NEJM, NIH, Nutrition, Pediatrics, Preventive Medicine, Wound Care | apples49 | January 16, 2015 10:36 pm | Comments (0)
October 19, 2014- Interviewed by Steven E. Greer, MD
Alessio Fasano, MD of Harvard discusses his 10-year-long study in children testing whether the delayed introduction of gluten into the diet reduced the eventual incidence of celiac disease. Dr. Fasano is most responsible for raising awareness of gluten intolerance after his 2003 NEJM and Archives of Internal Medicine papers were published.
July 27, 2012 By Steven Greer, MD
Andrew Bremer, MD, PhD, Pediatric endocrinologist at Vanderbilt University School of Medicine explains why sugary drinks are the best target to go after to cut obesity rates
